11-FLUORO-1,2,4,4A-TETRAHYDRO-2,4-DIMETHYL-8-((4R)-4-METHYL-2-OXO-3-OXAZOLIDINYL)SPIRO(ISOXAZOLO(4,5-G)(1,4)OXAZINO(4,3-A)QUINOLINE-5(6H),5'(2'H)-PYRIMIDINE)-2',4',6'(1'H,3'H)-TRIONE, (2R,4S,4AS)-
UNII XLW8PL4C7J
Substance Identification & Data
This profile provides standardized clinical and technical data for 11-fluoro-1,2,4,4a-tetrahydro-2,4-dimethyl-8-((4r)-4-methyl-2-oxo-3-oxazolidinyl)spiro(isoxazolo(4,5-g)(1,4)oxazino(4,3-a)quinoline-5(6h),5'(2'h)-pyrimidine)-2',4',6'(1'h,3'h)-trione, (2r,4s,4as)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) XLW8PL4C7J.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1620458-02-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H22FN5O7 ZSWMIFNWDQEXDT-SJBBUJNXSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 11-fluoro-1,2,4,4a-tetrahydro-2,4-dimethyl-8-((4r)-4-methyl-2-oxo-3-oxazolidinyl)spiro(isoxazolo(4,5-g)(1,4)oxazino(4,3-a)quinoline-5(6h),5'(2'h)-pyrimidine)-2',4',6'(1'h,3'h)-trione, (2r,4s,4as)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.